Literature DB >> 27246167

A critical look at the function of the P2Y11 receptor.

Karin Dreisig1, Birgitte Rahbek Kornum2,3.   

Abstract

The P2Y11 receptor is a member of the purinergic receptor family. It has been overlooked, somewhat due to the lack of a P2ry11 gene orthologue in the murine genome, which prevents the generation of knockout mice, which have been so helpful for defining the roles of other P2Y receptors. Furthermore, some of the studies reported to date have methodological shortcomings, making it difficult to determine the function of P2Y11 with certainty. In this review, we discuss the lack of a murine "P2Y11-like receptor" and highlight the limitations of the currently available methods used to investigate the P2Y11 receptor. These methods include protein recognition with antibodies that show very little specificity, gene expression studies that completely overlook the existence of a fusion transcript between the adjacent PPAN gene and P2RY11, and agonists/antagonists reported to be specific for the P2Y11 receptor but which have not been tested for activity on numerous other adenosine 5'-triphosphate (ATP)-binding receptors. We suggest a set of criteria for evaluating whether a dataset describes effects mediated by the P2Y11 receptor. Following these criteria, we conclude that the current evidence suggests a role for P2Y11 in immune activation with cell type-specific effects.

Entities:  

Keywords:  BzATP; NAD+; NF157; NF340; NF546; Rat

Mesh:

Substances:

Year:  2016        PMID: 27246167      PMCID: PMC5023629          DOI: 10.1007/s11302-016-9514-7

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  130 in total

1.  "Host tissue damage" signal ATP promotes non-directional migration and negatively regulates toll-like receptor signaling in human monocytes.

Authors:  Andreas Kaufmann; Boris Musset; Sven H Limberg; Vijay Renigunta; Rainer Sus; Alexander H Dalpke; Klaus M Heeg; Bernard Robaye; Peter J Hanley
Journal:  J Biol Chem       Date:  2005-07-19       Impact factor: 5.157

2.  Involvement of P2Y receptors in pyridoxal-5'-phosphate-induced cardiac preconditioning.

Authors:  Hervé Millart; Loubna Alouane; Floriane Oszust; Stephane Chevallier; Arnaud Robinet
Journal:  Fundam Clin Pharmacol       Date:  2009-04-28       Impact factor: 2.748

3.  ATPgammaS enhances the production of inflammatory mediators by a human dermal endothelial cell line via purinergic receptor signaling.

Authors:  Kristina Seiffert; W Ding; John A Wagner; Richard D Granstein
Journal:  J Invest Dermatol       Date:  2006-05       Impact factor: 8.551

4.  Activation of P2Y receptors stimulates potassium and cation currents in acutely isolated human Müller (glial) cells.

Authors:  Andreas Bringmann; Thomas Pannicke; Michael Weick; Bernd Biedermann; Susann Uhlmann; Leon Kohen; Peter Wiedemann; Andreas Reichenbach
Journal:  Glia       Date:  2002-02       Impact factor: 7.452

5.  Cloning, expression, signaling mechanisms, and membrane targeting of P2Y(11) receptors in Madin Darby canine kidney cells.

Authors:  A C Zambon; L L Brunton; K E Barrett; R J Hughes; B Torres; P A Insel
Journal:  Mol Pharmacol       Date:  2001-07       Impact factor: 4.436

Review 6.  Recent research on the biological activity of suramin.

Authors:  T E Voogd; E L Vansterkenburg; J Wilting; L H Janssen
Journal:  Pharmacol Rev       Date:  1993-06       Impact factor: 25.468

7.  The P2Y(2) nucleotide receptor mediates tissue factor expression in human coronary artery endothelial cells.

Authors:  Ling Ding; Wanshu Ma; Timothy Littmann; Riley Camp; Jianzhong Shen
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

8.  A selective high-affinity antagonist of the P2Y14 receptor inhibits UDP-glucose-stimulated chemotaxis of human neutrophils.

Authors:  Matthew O Barrett; Juliana I Sesma; Christopher B Ball; P Suresh Jayasekara; Kenneth A Jacobson; Eduardo R Lazarowski; T Kendall Harden
Journal:  Mol Pharmacol       Date:  2013-04-16       Impact factor: 4.436

9.  Extracellular NAD(+) induces a rise in [Ca(2+)](i) in activated human monocytes via engagement of P2Y(1) and P2Y(11) receptors.

Authors:  Carina Klein; Anja Grahnert; Aliaa Abdelrahman; Christa E Müller; Sunna Hauschildt
Journal:  Cell Calcium       Date:  2009-09-11       Impact factor: 6.817

10.  P2Y11 purinoceptor mediates the ATP-enhanced chemotactic response of rat neutrophils.

Authors:  Feras Alkayed; Masanori Kashimata; Noriko Koyama; Toru Hayashi; Yasuo Tamura; Yukio Azuma
Journal:  J Pharmacol Sci       Date:  2012-11-23       Impact factor: 3.337

View more
  24 in total

1.  The effect of purinergic signaling via the P2Y11 receptor on vascular function in a rat model of acute inflammation.

Authors:  Maria D Dănilă; Andreea Privistirescu; Oana M Duicu; Corina D Rațiu; Denis Angoulvant; Danina M Muntean; Adrian Sturza
Journal:  Mol Cell Biochem       Date:  2017-02-17       Impact factor: 3.396

2.  Lipopolysaccharide suppresses T cells by generating extracellular ATP that impairs their mitochondrial function via P2Y11 receptors.

Authors:  Koichiro Sueyoshi; Carola Ledderose; Yong Shen; Albert H Lee; Nathan I Shapiro; Wolfgang G Junger
Journal:  J Biol Chem       Date:  2019-02-20       Impact factor: 5.157

3.  The role of purinergic P2Y12 and P2Y13 receptors in ADPβS-induced inhibition of the cardioaccelerator sympathetic drive in pithed rats.

Authors:  Belinda Villanueva-Castillo; Eduardo Rivera-Mancilla; Kristian Agmund Haanes; Antoinette MaassenVanDenBrink; Carlos M Villalón
Journal:  Purinergic Signal       Date:  2020-02-17       Impact factor: 3.765

4.  Antagonism of P2Y11 receptor (P2Y11R) protects epidermal stem cells against UV-B irradiation.

Authors:  Yaguang Wu; Lan Ge; Song Li; Zhiqiang Song
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

5.  A Gs-coupled purinergic receptor boosts Ca2+ influx and vascular contractility during diabetic hyperglycemia.

Authors:  Maria Paz Prada; Arsalan U Syed; Olivia R Buonarati; Gopireddy R Reddy; Matthew A Nystoriak; Debapriya Ghosh; Sergi Simó; Daisuke Sato; Kent C Sasse; Sean M Ward; Luis F Santana; Yang K Xiang; Johannes W Hell; Madeline Nieves-Cintrón; Manuel F Navedo
Journal:  Elife       Date:  2019-03-01       Impact factor: 8.140

6.  Analysis of purine receptor expression and functionality in alveolar epithelial cells.

Authors:  Cynthia Olotu; Martina Kiefmann; Cornelia Ronneburg; Felix Lehmensiek; Annelie Cuvenhaus; Volker Meidl; Alwin E Goetz; Rainer Kiefmann
Journal:  Purinergic Signal       Date:  2020-03-31       Impact factor: 3.765

Review 7.  Update of P2Y receptor pharmacology: IUPHAR Review 27.

Authors:  Kenneth A Jacobson; Esmerilda G Delicado; Christian Gachet; Charles Kennedy; Ivar von Kügelgen; Beibei Li; M Teresa Miras-Portugal; Ivana Novak; Torsten Schöneberg; Raquel Perez-Sen; Doreen Thor; Beili Wu; Zhenlin Yang; Christa E Müller
Journal:  Br J Pharmacol       Date:  2020-04-06       Impact factor: 9.473

8.  The purinergic receptor P2Y11 choreographs the polarization, mitochondrial metabolism, and migration of T lymphocytes.

Authors:  Carola Ledderose; Sophie Bromberger; Christian J Slubowski; Koichiro Sueyoshi; Dilan Aytan; Yong Shen; Wolfgang G Junger
Journal:  Sci Signal       Date:  2020-09-29       Impact factor: 8.192

9.  β-Nicotinamide Adenine Dinucleotide (β-NAD) Inhibits ATP-Dependent IL-1β Release from Human Monocytic Cells.

Authors:  Sebastian Daniel Hiller; Sarah Heldmann; Katrin Richter; Innokentij Jurastow; Mira Küllmar; Andreas Hecker; Sigrid Wilker; Gabriele Fuchs-Moll; Ivan Manzini; Günther Schmalzing; Wolfgang Kummer; Winfried Padberg; J Michael McIntosh; Jelena Damm; Anna Zakrzewicz; Veronika Grau
Journal:  Int J Mol Sci       Date:  2018-04-10       Impact factor: 5.923

10.  Exogenous NAD+ Stimulates MUC2 Expression in LS 174T Goblet Cells via the PLC-Delta/PTGES/PKC-Delta/ERK/CREB Signaling Pathway.

Authors:  Seongho Ma; Jiah Yeom; Young-Hee Lim
Journal:  Biomolecules       Date:  2020-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.